Ark Therapeutics Group plc
 
Latest News
Completion of the dose ranging Phase I section of refractory angina clinical study
16 May 2012
spacer
Substantial EU FP7 Grant and Notice of Allowance of US Patent in respect of EG013
02 May 2012
spacer
Ark's newest manufacturing suite receives GMP approval
25 April 2012
spacer
Read more news stories here
Investor relations
1st Interim Statement published
17 May 2012
spacer
2011 Annual Report published
21 March 2012
spacer
2011 Interim Report published
24 August 2011
spacer
Visit the Investor Relations section of the web site.
Share Price
2.88 p
Change: 0.16p
Last Trade: 17/5/2012 22:06
View share price data
spacer
Search Site
Use the search form below to search our site.

spacer
Annual Report
Download the latest Annual Report & Accounts
PDF Format
[1.35MB]
Annual Report
spacer
Keep up-to-date
Keep up-to-date with product developments, investor relations information and news with our email updates. Register here to receive our email alerts.
spacer